Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer

Journal of Geriatric Oncology

Volumn 3, Issue 3, 2012, Pages 228-237

  Prithviraj, Gopi K ^a   Koroukian, Siran ^b,c   Margevicius, Seunghee ^c   Berger, Nathan A ^a,b   Bagai, Rakesh ^d   Owusu, Cynthia ^a,b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Inappropriate prescribing; Older; Polypharmacy

Indexed keywords

CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIGOXIN; IRON; LORAZEPAM; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; EDUCATIONAL STATUS; FEMALE; GERIATRIC PATIENT; HIGH RISK PATIENT; HIGH SCHOOL; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTCOME ASSESSMENT; POLYPHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; UNDERWEIGHT;

EID: 84862504379     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2012.02.005     Document Type: Article

References (46)

1. Steinman M.A., Landefeld C.S., Rosenthal G.E., Berthenthal D., Sen S., Kaboli P.J. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006, 54(10):1516-1523.
2. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclean J.R., Beers M.H. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003, 163(22):2716-2724.
3. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997, 157(14):1531-1536.
4. Beers M.H., Ouslander J.G., Rollingher I., Reuben D.B., Brooks J., Beck J.C. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991, 151(9):1825-1832.
5. Lichtman S.M., Boparai M.K. Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy. Curr Treat Options Oncol 2008, 9(2-3):191-203.
6. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007, 5(4):345-351.
7. Lau D.T., Kasper J.D., Potter D.E., Lyles A., Bennett R.G. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005, 165(1):68-74.
8. Hamilton H.J., Gallagher P.F., O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009, 9:5.
9. Ryan C., O'Mahony D., Kennedy J., Weedle P., Barry P., Gallagher P., et al. Appropriate prescribing in the elderly: an investigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improved prescribing in the elderly tool to identify inappropriate use of medicines in the elderly in primary care in Ireland. J Clin Pharm Ther 2009, 34(4):369-376.
10. Hanlon J.T., Fillenbaum G.G., Kuchibhatla M., Artz M.B., Boult C., Gross C.R., et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002, 40(2):166-176.
11. Agostini J.V., Han L., Tinetti M.E. The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc 2004, 52(10):1719-1723.
12. Weiner D.K., Hanlon J.T., Studenski S.A. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998, 44(4):217-221.
13. Field T.S., Gurwitz J.H., Avorn J., McCormick D., Jain S., Eckler M., et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001, 161(13):1629-1634.
14. Riechelmann R.P., Tannock I.F., Wang L., Saad E.D., Taback N.A., Krzyzanowska M.K. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007, 99(8):592-600.
15. Flood K.L., Carroll M.B., Le C.V., Brown C.J. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother 2009, 7(3):151-158.
16. Maggiore R.J., Gross C.P., Hurria A. Polypharmacy in older adults with cancer. Oncologist 2010, 15(5):507-522.
17. Tam-McDevitt J. Polypharmacy, aging, and cancer. Oncology 2008, (9):1052-1055. Williston Park, NY., discussion 5, 8, 60.
18. Misra D., Seo P.H., Cohen H.J. Aging and cancer. Clin Adv Hematol Oncol 2004, 2(7):457-465.
19. Corcoran M.E. Polypharmacy in the older patient with cancer. Cancer Control 1997, 4(5):419-428.
20. Laroche M.L., Charmes J.P., Nouaille Y., Picard N., Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly?. Br J Clin Pharmacol 2007, 63(2):177-186.
21. Fillenbaum G.G., Hanlon J.T., Landerman L.R., Artz M.B., O'Connor H., Dowd B., et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother 2004, 2(2):92-101.
22. Lund B.C., Carnahan R.M., Egge J.A., Chrischilles E.A., Kaboli P.J. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010, 44(6):957-963.
23. Aparasu R.R., Mort J.R. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother 2000, 34(3):338-346.
24. Gallagher P.F., Barry P.J., Ryan C., Hartigan I., O'Mahony D. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing 2008, 37(1):96-101.
25. Chang C.M., Liu P.Y., Yang Y.H., Yang Y.C., Wu C.F., Lu F.H. Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy 2005, 25(6):831-838.
26. Chrischilles E.A., VanGilder R., Wright K., Kelly M., Wallace R.B. Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults. J Am Geriatr Soc 2009, 57(6):1000-1006.
27. Sokol K.C., Knudsen J.F., Li M.M. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007, 32(2):169-175.
28. Haider S.I., Johnell K., Weitoft G.R., Thorslund M., Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc 2009, 57(1):62-69.
29. Linjakumpu T., Hartikainen S., Klaukka T., Veijola J., Kivela S.L., Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002, 55(8):809-817.
30. Jorgensen T., Johansson S., Kennerfalk A., Wallander M.A., Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001, 35(9):1004-1009.
31. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
32. Crum R.M., Anthony J.C., Bassett S.S., Folstein M.F. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993, 269(18):2386-2391.
33. Sherbourne C.D., Stewart A.L. The MOS social support survey. Soc Sci Med 1991, 32(6):705-714.
34. Fulton M.M., Allen E.R. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005, 17(4):123-132.
35. Pugh M.J., Palmer R.F., Parchman M.L., Mortensen E., Markides K., Espino D.V. Association of suboptimal prescribing and change in lower extremity physical function over time. Gerontology 2007, 53(6):445-453.
36. Lai S.W., Liao K.F., Liao C.C., Muo C.H., Liu C.S., Sung F.C. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine 2010, 89(5):295-299.
37. Gnjidic D., Cumming R.G., Le Couteur D.G., Handelsman D.J., Naganathan V., Abernethy D.R., et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009, 68(1):97-105.
38. Lichtman S.M. Guidelines for the treatment of elderly cancer patients. Cancer Control 2003, 10(6):445-453.
39. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol 2001, 56(3):M146-M156.
40. Tully C.L., Snowdon D.A. Weight change and physical function in older women: findings from the Nun Study. J Am Geriatr Soc 1995, 43(12):1394-1397.
41. Newman A.B., Yanez D., Harris T., Duxbury A., Enright P.L., Fried L.P. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001, 49(10):1309-1318.
42. Halvorsen K.H., Ruths S., Granas A.G., Viktil K.K. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care 2010, 28(2):82-88.
43. Denneboom W., Dautzenberg M.G., Grol R., De Smet P.A. Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel. Br J Gen Pract 2006, 56(528):504-510.
44. Klopotowska J.E., Wierenga P.C., de Rooij S.E., Stuijt C.C., Arisz L., Kuks P.F., et al. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy In Newly admitted Geriatric Seniors). BMC Health Serv Res 2011, 11(1):124.
45. Hanlon J.T., Weinberger M., Samsa G.P., Schmader K.E., Uttech K.M., Lewis I.K., et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996, 100(4):428-437.
46. Cowper P.A., Weinberger M., Hanlon J.T., Landsman P.B., Samsa G.P., Uttech K.M. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998, 18(2):327-332.